DNA-PK inhibition by M3814 enhances chemosensitivity in non-small cell lung cancer
A significant proportion of non-small cell lung cancer (NSCLC) patients experience accumulating chemotherapy-related adverse events, motivating the design of chemosensitizating strategies. The main cytotoxic damage induced by chemotherapeutic agents is DNA double-strand breaks (DSB). It is thus conc...
Saved in:
Main Authors: | Manni Wang (Author), Siyuan Chen (Author), Yuquan Wei (Author), Xiawei Wei (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Small molecules, inhibitors of DNA-PK, targeting DNA repair and beyond
by: David eDavidson, et al.
Published: (2013) -
Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway
by: Ren T, et al.
Published: (2014) -
In vitro PK/PD modeling of tyrosine kinase inhibitors in non‐small cell lung cancer cell lines
by: Linda Wanika, et al.
Published: (2024) -
The Chinese medicine JC-001 enhances the chemosensitivity of Lewis lung tumors to cisplatin by modulating the immune response
by: Meng-Hsien Chuang, et al.
Published: (2017) -
GSK-3β inhibits autophagy and enhances radiosensitivity in non-small cell lung cancer
by: Jialin Ren, et al.
Published: (2018)